alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### Diana D. Du Broff, Also Known as Diana E. Wiesner, Appellant, v. Gustave A. Gerber, Respondent, et al., Defendant.

In an action to recover damages for alleged fraud, plaintiff appeals, as limited by her brief, from so much of an order of the Supreme Court, Queens County, entered May 2, 1967, as dismissed the first, third, fourth and fifth causes of action, upon the trial court’s decision during a jury trial. Order modified, on the law, by striking therefrom the second decretal paragraph, which dismissed the third cause of action, and by substituting therefor a provision denying the motion to dismiss that cause of action. As so modified, order affirmed insofar as appealed from, with costs to appellant to abide the event of the new trial. No questions of fact were considered. In our opinion, sufficient was proved by plaintiff to warrant the submission of the third cause of action to the jury. Christ, Acting P. J., Brennan, Hopkins, Munder and Kleinfeld, JJ., concur.
<PAGE>


EXHIBIT 21.01
LIST OF REGISTRANT'S SUBSIDIARIES

<TABLE>
<CAPTION>

                                                                                        AMOUNT OWNED
     NAME                                              JURISDICTION                     BY REGISTRANT
     ----                                              ------------                     -------------
<S>                                                    <C>                              <C>
HNC Insurance Solutions, Inc.                           California                             100%
eHNC Inc.                                               Delaware                               100%
Retek Information Systems Inc.*                         Delaware                                86%
Retek Information Systems, Inc.*                        Canada                                  86%
Retek Information Systems, Limited*                     United Kingdom                          86%
Retek Information System Pty Ltd*                       Australia                               86%
Retek Information System*                               France                                  86%
Retek Information Systems GmbH*                         Germany                                 86%
WebTrak Limited*                                        United Kingdom                          86%
Retek Inc.**                                            Delaware                                86%
HNC Financial Solutions, Inc. ***                       Illinois                               100%
HNC Software International, Inc.                        Delaware                               100%
Center for Adaptive Systems Applications, Inc.          Delaware                               100%
Onyx Technologies, Inc.                                 Georgia                                100%
Advanced Information Management Solutions, Inc.         California                             100%

</TABLE>

(* wholly owned subsidiary of Retek Inc.)
(** formerly Practical Control Systems Technologies, Inc. and Retek Logistics,
    Inc.)
(*** formerly Financial Technology, Inc.)
#### § 1.278 Who is authorized to submit prior notice?

A prior notice for an article of food may be submitted by any person with knowledge of the required information. This person is the submitter. The submitter also may use another person to transmit the required information on his/her behalf. The person who transmits the information is the transmitter. The submitter and transmitter may be the same person.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The concept meeting, proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Child Health and Human Development Special Emphasis Panel. Contraceptive Clinical Trials Network.                    

*Date:*                         January 12, 2011.                    

*Time:*                         1 p.m. to 3 p.m.                    

*Agenda:*                         To review and evaluate concept review.                    

*Place:*                         National Institutes of Health, 6100 Executive Boulevard, Room 2A01, Rockville, MD 20852. (Telephone Conference Call).                    

*Contact Person:*                         Sathasiva B. Kandasamy, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, 6100 Executive Boulevard, Rockville, Md 20892-9304. (301) 435-6680.                         *skandasa@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment program, National Institutes of Health, HHS)

                        Dated:                         *December 27, 2010.*

Jennifer S. Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-33067 Filed 12-30-10; 8:45 am]

BILLING CODE 4140-01-P
Exhibit 31.2  CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002  I, Brent A. Beecham, Chief Financial Officer of SBH ASSOCIATES, INC. (the "Company"), certify that:  1. I have reviewed this annual report on Form 10-K of SBH ASSOCIATES, INC.;  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;  4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;  b) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and  c) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and  5. I, as the certifying officer have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.  Date: January 13, 2016 By: /s/BRENT A. BEECHAM Brent A. Beecham Chief Financial Officer
§ 910.133 Deviation authority. ( a ) *General.* ( 1 ) A deviation is the use of any policy, procedure, form, standard, term, or condition which varies from a requirement of this part, or the waiver of any such requirement, unless such use or waiver is authorized or precluded by Federal statute. The use of optional or discretionary provisions of this part, including special restrictive conditions used in accordance with § 910.372, exceptions under 2 CFR 200.102, and the waiver of the cost sharing requirements in § 910.130 are not deviations. Awards to foreign entities are not subject to this section.
( 2 ) A single-case deviation is a deviation which applies to one financial assistance transaction and one applicant, recipient, or subrecipient only.
( 3 ) A class deviation is a deviation which applies to more than one financial assistance transaction, applicant, recipient, or subrecipient.
( b ) *Conditions for approval.* The DOE/NNSA officials specified in paragraph (c) of this section may authorize a deviation only upon a written determination that the deviation is— ( 1 ) Necessary to achieve program objectives;
( 2 ) Necessary to conserve public funds;
( 3 ) Otherwise essential to the public interest; or
( 4 ) Necessary to achieve equity.
( c ) *Approval procedures.* ( 1 ) A deviation request must be in writing and must be submitted to the responsible DOE/NNSA Contracting Officer. An applicant for a subaward or a subrecipient shall submit any such request through the recipient.
( 2 ) Except as provided in paragraph (c)(3) of this section— ( i ) A single-case deviation may be authorized by the responsible HCA.
( ii ) A class deviation may be authorized by the Director, Office of Acquisition Management, for DOE actions, and the Deputy Associate Administrator for the Office of Acquisition and Project Management for NNSA, for NNSA actions, or designee.
( 3 ) Whenever the approval of OMB, other Federal agency, or other DOE/NNSA office is required to authorize a deviation, the proposed deviation must be submitted to the Director, Office of Acquisition Management, for DOE actions, and the Deputy Associate Administrator for the Office of Acquisition and Project Management for NNSA, for NNSA actions, or designee for concurrence prior to submission to the authorizing official.
( d ) *Notice.* Whenever a request for a class deviation is approved, DOE/NNSA will identify this class deviation (as applicable) in the Notice of Funding Opportunity(s) that may be affected.
( e ) *Subawards.* A recipient may use a deviation in a subaward only with the prior written approval of a DOE/NNSA Contracting Officer.
[85 FR 32979, June 1, 2020]
#### § 830.200 Scope.

This Subpart establishes safety basis requirements for Hazard Category 1, 2, and 3 DOE nuclear facilities.
#### § 1800.400 Policy guide.

###### Cross Reference

Link to an amendment published at 89 FR 75948, Sept. 17, 2024.

Payment of fee or profit is consistent with an activity whose principal purpose is the acquisition of goods and services for the direct benefit or use of the United States Government, rather than an activity whose principal purpose is Federal financial assistance to a recipient to carry out a public purpose. Therefore, the Grants Officer shall use a procurement contract, rather than a grant or cooperative agreement, in all cases where fee or profit is to be paid to the recipient of the instrument or the instrument is to be used to carry out a program where fee or profit is necessary to achieving program objectives. Grants and cooperative agreements shall not provide for the payment of any fee or profit to the recipient.

[85 FR 71817, Nov. 12, 2020]
#### The People of the State of New York, Respondent, v Wilbert Boyd, Appellant.

Appeal by defendant from a judgment of the Supreme Court, Kings County, rendered February 22, 1979, convicting him of robbery in the third degree, upon a plea of guilty, and imposing sentence. Judgment affirmed. We have reviewed the record and agree with defendant’s assigned counsel that there are no meritorious grounds which could be raised on this appeal. Counsel’s application for leave to withdraw as counsel is granted. (See *Anders v California,*386 US 738; *People v Paige,*54 AD2d 631; cf. *People v Gonzalez,*47 NY2d 606.) Hopkins, J. P., Mangano, O’Connor and Weinstein, JJ., concur.
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                           7,517
<SECURITIES>                                     7,353
<RECEIVABLES>                                   20,091
<ALLOWANCES>                                     (623)
<INVENTORY>                                        611
<CURRENT-ASSETS>                                42,607
<PP&E>                                          10,556
<DEPRECIATION>                                 (4,600)
<TOTAL-ASSETS>                                  94,219
<CURRENT-LIABILITIES>                           11,123
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            19
<OTHER-SE>                                      82,394
<TOTAL-LIABILITY-AND-EQUITY>                    94,219
<SALES>                                         53,833
<TOTAL-REVENUES>                                53,833
<CGS>                                           19,105
<TOTAL-COSTS>                                   19,105
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 478
<INCOME-PRETAX>                                  5,768
<INCOME-TAX>                                     (608)
<INCOME-CONTINUING>                              6,376
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     6,376
<EPS-PRIMARY>                                      .31
<EPS-DILUTED>                                      .31


</TABLE>
§ 3485.415 What must I do if a Federal agency excludes the participant or a principal after I enter into a covered transaction? ( a ) You as a Federal agency official may continue covered transactions with an excluded person, or under which an excluded person is a principal, if the transactions were in existence when the person was excluded. You are not required to continue the transactions, however, and you may consider termination. You should make a decision about whether to terminate and the type of termination action, if any, only after a thorough review to ensure that the action is proper.
( b ) You may not renew or extend covered transactions (other than no-cost time extensions) with any excluded person, or under which an excluded person is a principal, unless you obtain an exception under § 3485.137.
( c ) *Title IV, HEA transactions.* If you are a title IV, HEA participant— ( 1 ) You may not renew or extend the term of any contract or agreement for the services of an excluded person as a principal with respect to a title IV, HEA transaction; and
( 2 ) You may not continue to use the services of that excluded person as a principal under this kind of an agreement or arrangement more than 90 days after you learn of the exclusion or after the close of the Federal fiscal year in which the exclusion takes effect, whichever is later.
(Authority: E.O. 12549 (3 CFR 1986 Comp., p. 189); E.O. 12689 (3 CFR 1989 Comp., p. 235); sec. 2455, Pub. L. 103-355, 108 Stat. 3327 (31 U.S.C. 6101 note); 20 U.S.C. 1082, 1094, 1221e-3, and 3474)
IV 

House Calendar No. 53 

115TH CONGRESS 

1ST SESSION H. RES. 374 

[Report No. 115–162] 

Providing for consideration of the bill (H.R. 2213) to amend the AntiBorder Corruption Act of 2010 to authorize certain polygraph waiver 

authority, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 6, 2017 

Ms. CHENEY, from the Committee on Rules, reported the following resolution; 

which was referred to the House Calendar and ordered to be printed 

RESOLUTION 

Providing for consideration of the bill (H.R. 2213) to amend 

the Anti-Border Corruption Act of 2010 to authorize 

certain polygraph waiver authority, and for other purposes. 

1 Resolved, That upon adoption of this resolution it 

2 shall be in order to consider in the House the bill (H.R. 

3 2213) to amend the Anti-Border Corruption Act of 2010 

4 to authorize certain polygraph waiver authority, and for 

5 other purposes. All points of order against consideration 

6 of the bill are waived. The amendment in the nature of 

mstockstill on DSK30JT082PROD with BILLS

2 

•HRES 374 RH 

1 a substitute recommended by the Committee on Homeland 

2 Security now printed in the bill shall be considered as 

3 adopted. The bill, as amended, shall be considered as read. 

4 All points of order against provisions in the bill, as amend5 ed, are waived. The previous question shall be considered 

6 as ordered on the bill, as amended, and on any further 

7 amendment thereto, to final passage without intervening 

8 motion except: (1) one hour of debate equally divided and 

9 controlled by the chair and ranking minority member of 

10 the Committee on Homeland Security; (2) the further 

11 amendment printed in the report of the Committee on 

12 Rules accompanying this resolution, if offered by the 

13 Member designated in the report, which shall be in order 

14 without intervention of any point of order, shall be consid15 ered as read, shall be separately debatable for the time 

16 specified in the report equally divided and controlled by 

17 the proponent and an opponent, and shall not be subject 

18 to a demand for division of the question; and (3) one mo19 tion to recommit with or without instructions. 

mstockstill on DSK30JT082PROD with BILLS

mstockstill on DSK30JT082PROD with BILLS

House Calendar No. 53 

115TH CONGRESS 

1ST SESSION H. RES. 374 

[Report No. 115–162] 

RESOLUTION 

Providing for consideration of the bill (H.R. 2213) 

thority, and for other purposes. 2010 to authorize certain polygraph waiver auto amend the Anti-Border Corruption Act of 

JUNE 6, 2017 

Referred to the House Calendar and ordered to be 

printed 

mstockstill on DSK30JT082PROD with BILLS
# EUR-Lex - 31966R0172 - EN

Avis juridique important

*|*

# 31966R0172

**Regulation No 172/66/EEC of the Commission of 5 November 1966 fixing coefficients for the different varieties and qualities of unrefined olive oil **

*
Official Journal 202 , 07/11/1966 P. 3481 - 3482 Finnish special edition: Chapter 3 Volume 1 P. 0181 Danish special edition: Series I Chapter 1965-1966 P. 0223 Swedish special edition: Chapter 3 Volume 1 P. 0181 English special edition: Series I Chapter 1965-1966 P. 0255 Greek special edition: Chapter 03 Volume 2 P. 0057 Spanish special edition: Chapter 03 Volume 1 P. 0237 Portuguese special edition Chapter 03 Volume 1 P. 0237 *

REGULATION No 172/66/EEC OF THE COMMISSION of 5 November 1966 fixing coefficients of equivalence for the different varieties and qualities of unrefined olive oil

THE COMMISSION OF THE EUROPEAN ECONOMIC COMMUNITY,

Having regard to the Treaty establishing the European Economic Community;

Having regard to Council Regulation No 136/66/EEC 1 of 22 September 1966 on the establishment of a common organisation of the market in oils and fats, and in particular Article 13 (4) thereof;

Having regard to Council Regulation No 162/66/EEC 2 of 27 October 1966 on trade in oils and fats between the Community and Greece, and in particular Article 3 (4) thereof;

Whereas the offers used in determining the c.i.f. price and the free-at-frontier price referred to respectively in Article 13 of Regulation No 136/66/EEC and Article 3 of Regulation No 162/66/EEC must be adjusted to allow for any deviations from the description of quality for which the threshold price was fixed ; whereas such adjustments must be made by means of coefficients of equivalence;

Whereas such coefficients of equivalence may be fixed while taking account of the differences between the value of the oil of the description and quality for which the threshold price was fixed and that of other description and qualities, such differences arising from the preference of buyers for better quality oils and from the costs borne by processors using oils which are not directly edible;

Whereas the measures provided for in this Regulation are in accordance with the Opinion of the Management Committee for Oils and Fats;

HAS ADOPTED THIS REGULATION:

Article 1

The adjustments referred to in the last paragraph of Article 13 (2) of Regulation No 136/66/EEC and in Article 3 (2) of Regulation No 162/66/EEC shall be made by applying the coefficients of equivalence fixed in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the third day following its publication in the Official Journal of the European Communities.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 5 November 1966.

For the Commission

The President

Walter HALLSTEIN

1 OJ No 172, 30.9.1966, p. 3025/66. 2 OJ No 197, 29.10.1966, p. 3393/66.

ANNEX Coefficients of equivalence for the different varieties and qualities of unrefined olive oil >PIC FILE= "T0019181">
§ 2520.20 Does this part apply to me? This part and, through this part, pertinent portions of the OMB guidance in subparts A through I of 2 CFR part 180 (see table at 2 CFR 180.100(b)) apply to you if you are a— ( a ) Participant or principal in a “covered transaction” (see Subpart B of 2 CFR part 180 and the definition of “nonprocurement transaction” at 2 CFR 180.970).
( b ) Respondent in an NSF suspension or debarment action.
( c ) NSF debarment or suspension official.
( d ) NSF grants officer, agreements officer, or other official authorized to enter into any type of nonprocurement transaction that is a covered transaction.